compounding semaglutide fda enforcement news today Compound versions of GLP-1 drugs for weight loss halted by fda compounding semaglutide enforcement october

Weight loss stalls or slows dramatically

Gastrointestinal side effects, while common, rarely lead to treatment discontinuation

While medications like Ozempic and Wegovy brought the power of GLP-1 agonists to the mainstream, 2026 marks the arrival of even more advanced therapies

You don't want it to freeze, so avoid direct contact with the cold packs if they are frozen solidwrap the vial in some bubble wrap or place it in a secondary container as a buffer

Another barrier is that following production in the body, DPP-4 rapidly breaks down incretins

The researchers wondered whether the genetic glitch also affects GLP-1, a gut hormone that plays an important role in blood sugar control after a meal by stimulating insulin release, slowing stomach emptying and reducing appetite